USPTO Examiner ROBINSON KEITH O NEAL - Art Unit 1661

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18831808Miniature Rose Plant Named 'Poulty046'September 2025January 2026Allow410NoNo
18831788Epimedium plant named 'Jester's Hat'September 2025November 2025Allow200NoNo
19317124Kalanchoe Plant Named 'KLEKB24054'September 2025November 2025Allow200NoNo
19316629PHALAENOPSIS PLANT NAMED 'PHA569755'September 2025November 2025Allow200NoNo
19315584ANTHURIUM PLANT NAMED 'AN2297549'August 2025November 2025Allow200NoNo
19313620MANDEVILLA PLANT NAMED 'TVMD1037'August 2025November 2025Allow300NoNo
19313568MANDEVILLA PLANT NAMED 'TVMD932'August 2025November 2025Allow200YesNo
19307947Dahlia Plant Named 'KLEDH24725'August 2025October 2025Allow200NoNo
19307610BEGONIA PLANT NAMED 'BEYZ0007'August 2025December 2025Allow410NoNo
18831685Grapevine plant named `SV35-5-61'July 2025November 2025Allow410NoNo
19274554Brunnera Plant Named 'HBBM19'July 2025August 2025Allow100YesNo
19274523Carex Plant Named 'Lunar Falls'July 2025September 2025Allow200NoNo
18831683Grapevine plant named 'SV34-130-197'July 2025October 2025Allow310NoNo
19271574STRAWBERRY PLANT NAMED 'SB_17_116-071'July 2025October 2025Allow300NoNo
19271418AGLAONEMA PLANT NAMED 'MUKSTIL'July 2025September 2025Allow200NoNo
19271593STRAWBERRY PLANT NAMED 'SB_17_106-052'July 2025October 2025Allow300NoNo
19271469STRAWBERRY PLANT NAMED 'SB_17_122-093'July 2025October 2025Allow300NoNo
19269809Petunia Plant Named 'KLEPH24833'July 2025September 2025Allow200NoNo
19270342STRAWBERRY PLANT NAMED 'SB_17_058-032'July 2025October 2025Allow300NoNo
19268767Petunia Plant Named 'KLEPH24827'July 2025September 2025Allow200NoNo
19268712Petunia Plant Named 'KLEPH24743'July 2025September 2025Allow200NoNo
19243682PHALAENOPSIS PLANT NAMED 'TALK SHOW'June 2025December 2025Allow600NoNo
19219576GRAPEVINE PLANT NAMED 'BLOMG04'May 2025October 2025Allow510NoNo
19207175CISSUS PLANT NAMED 'G4Y0001'May 2025July 2025Allow310NoNo
19195206Aristeria plant named 'D Grey Moon'April 2025September 2025Allow410NoNo
19194236Strawberry Plant Named 'BACHATA'April 2025October 2025Allow610NoNo
18831574Delphinium plant named 'Violets Are Blue'April 2025August 2025Allow400NoNo
18831568Lavandula plant named 'Summer Serenade'April 2025December 2025Allow810NoNo
19189152Delosperma Plant Named ‘T2173’April 2025June 2025Allow200NoNo
19189144Delosperma Plant Named 'T2160'April 2025June 2025Allow200NoNo
19185916Hydrangea plant named 'RNR X AS-01-22'April 2025August 2025Allow410NoNo
19183795ALOCASIA PLANT NAMED 'SILVER WINGS'April 2025July 2025Allow300NoNo
19183823EUPHORBIA PLANT NAMED 'BONPRI 16P5'April 2025August 2025Allow400NoNo
19183791ALOCASIA PLANT NAMED 'DRAGON WINGS'April 2025July 2025Allow310NoNo
19183660Peach Tree Named 'Threefoldpeachone'April 2025October 2025Allow610NoNo
19182712Deutzia Plant Named 'LISSTODEL'April 2025August 2025Allow410NoNo
19182941MANDARIN PLANT NAMED 'Mikanken14'April 2025October 2025Allow610NoNo
19181402SEASHORE PASPALUM PLANT NAMED 'UGP 73'April 2025February 2026Allow1010NoNo
19179138Aloe vera plant named 'Silvera Moonfire'April 2025October 2025Allow610NoNo
18831547Grapevine Plant Named 'SV36-47-269'April 2025October 2025Allow610NoNo
19171336PHALAENOPSIS PLANT NAMED 'SOUNDTRACK'April 2025May 2025Allow100NoNo
19171334PHALAENOPSIS PLANT NAMED 'LANDMARK'April 2025May 2025Allow100NoNo
19093545ORNAMENTAL SWEETPOTATO PLANT NAMED ‘NCORNSP-034SCVPG’March 2025October 2025Allow710NoNo
19086806OLIVE TREE NAMED 'I-51'March 2025September 2025Allow610NoNo
19083845Ulmus tree named 'UCMTF'March 2025September 2025Allow610NoNo
18831503Epimedium plant named 'Wisteria Falls'March 2025June 2025Allow300NoNo
18831487Lomandra plant named 'LM380'February 2025October 2025Allow810NoNo
19055613CHRYSANTHEMUM PLANT NAMED 'CIFZ0119'February 2025September 2025Allow710NoNo
19055251SANVITALIA PLANT NAMED 'DOSANSUSUGO24'February 2025May 2025Allow300NoNo
19055212CALIBRACHOA PLANT NAMED 'DOCALALKOTIBU'February 2025August 2025Allow600NoNo
19054045CALIBRACHOA PLANT NAMED 'DOCALBLOSU'February 2025May 2025Allow300NoNo
19054476Grape Plant Named 'Resilience'February 2025April 2025Allow200NoNo
19048854Cortaderia Plant Named 'Day3'February 2025April 2025Allow200NoNo
19048852Prunus Plant Named 'Frerichs 01'February 2025April 2025Allow200NoNo
19045644Colocasia Plant Named 'Hawaiian Luau'February 2025August 2025Allow710NoNo
19042162Floribunda Rose Plant Named 'KORneukap'January 2025April 2025Allow300NoNo
19042479GRAPEVINE PLANT NAMED ‘SUGRA65’January 2025July 2025Allow510NoNo
19043017GRAPEVINE PLANT NAMED ‘SUGRA70’January 2025September 2025Allow810NoNo
18831462Baptisia plant named 'Golden Anniversary’January 2025August 2025Allow610NoNo
19037040Rudbeckia Plant Named 'RUDBSUN303'January 2025April 2025Allow200NoNo
19033437Hydrangea Plant Named 'Bailmacnine'January 2025April 2025Allow200NoNo
19031798POINSETTIA PLANT NAMED 'DOEUPRERIB'January 2025October 2025Allow910NoNo
19031512Camellia Plant Named 'Green 01-019'January 2025June 2025Allow510NoNo
19030116HYDRANGEA PLANT NAMED 'HORE9306'January 2025October 2025Allow910NoNo
19025623Grapevine Plant Named 'MN 1325'January 2025May 2025Allow400NoNo
19026204Impatiens plant named 'DIMPSLPRWT'January 2025April 2025Allow300NoNo
19025361Garden Culinary Salvia plant named 'G22088'January 2025July 2025Allow610NoNo
18831405Ficus plant named 'ESFIBU1801'January 2025August 2025Allow710NoNo
18831404Ficus plant named 'ESPE2006'January 2025September 2025Allow810NoNo
19004780Shrub Rose Plant Named 'Radmeadow'December 2024August 2025Allow810NoNo
19005033Grandiflora Rose Plant Named 'KORdreimela'December 2024July 2025Allow700NoNo
19004826Dampiera Plant Named 'Altmp2336'December 2024August 2025Allow810NoNo
19004919Hibiscus Plant Named 'Minsycbb2b'December 2024July 2025Allow700NoNo
19000529Sansevieria plant named 'Hansoti46'December 2024July 2025Allow610NoNo
19000540Sansevieria plant named 'Hansoti48'December 2024July 2025Allow610NoNo
18989326Miniature Rose Plant Named 'KORpot126'December 2024July 2025Allow700NoNo
18988305Calibrachoa Plant Named 'KLECA23987'December 2024July 2025Allow710NoNo
18985473Heuchera plant named 'FJF 1811'December 2024July 2025Allow710NoNo
18831368Scirpus pendulus plant named 'Stars and Stripes'December 2024July 2025Allow710NoNo
18978805Bedding Rose Plant Named 'MEIWENTAR'December 2024March 2025Allow300NoNo
18978302Paeonia plant named 'Smithopus8'December 2024May 2025Allow510NoNo
18976831Agapanthus Plant Named 'FO21BM110'December 2024March 2025Allow300NoNo
18972659STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDTEN'December 2024March 2025Allow300NoNo
18966566Paeonia plant named 'Smithopus10'December 2024May 2025Allow510NoNo
18964906Aronia plant named 'UCONNAA001'December 2024April 2025Allow410NoNo
18964940Hibiscus plant named 'RWoods7'December 2024June 2025Allow610NoNo
18957669Lagerstroemia Plant Named 'GV16103'November 2024February 2025Allow300NoNo
18956337CALIBRACHOA PLANT NAMED 'WNCALSBDBLGF26'November 2024February 2025Allow300NoNo
18956474LOBULARIA PLANT NAMED 'INLBUWHIGT'November 2024May 2025Allow500NoNo
18956442LOBELIA PLANT NAMED 'WNLOBLRA26'November 2024February 2025Allow300NoNo
18957357HYBRID TEA ROSE PLANT NAMED 'WEKSELYAN'November 2024February 2025Allow300NoNo
18955808HELLEBORUS PLANT NAMED 'BORUSMURA25'November 2024February 2025Allow300NoNo
18951034Miscanthus plant named 'Lady in Red'November 2024April 2025Allow510NoNo
18947631DIERVILLA PLANT NAMED 'SMNDSN'November 2024May 2025Allow600NoNo
18947510BUDDLEIA PLANT NAMED 'SMNBAB'November 2024February 2025Allow300NoNo
18947423ABELIA PLANT NAMED 'SMNAMW'November 2024April 2025Allow500NoNo
18947467BIGNONIA PLANT NAMED 'SMNBFW'November 2024February 2025Allow300NoNo
18947584DIERVILLA PLANT NAMED 'SMNDSF'November 2024May 2025Allow600NoNo
18947758SYRINGA PLANT NAMED 'SMNSPWF'November 2024January 2025Allow200NoNo
18946906PHALAENOPSIS PLANT NAMED 'MI02815'November 2024January 2025Allow300NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBINSON, KEITH O NEAL.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
1.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
10
(40.0%)
Not Allowed After Appeal Filing
15
(60.0%)
Filing Benefit Percentile
65.0%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ROBINSON, KEITH O NEAL - Prosecution Strategy Guide

Executive Summary

Examiner ROBINSON, KEITH O NEAL works in Art Unit 1661 and has examined 1,576 patent applications in our dataset. With an allowance rate of 95.8%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 16 months.

Allowance Patterns

Examiner ROBINSON, KEITH O NEAL's allowance rate of 95.8% places them in the 85% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ROBINSON, KEITH O NEAL receive 0.78 office actions before reaching final disposition. This places the examiner in the 5% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ROBINSON, KEITH O NEAL is 16 months. This places the examiner in the 98% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -0.9% benefit to allowance rate for applications examined by ROBINSON, KEITH O NEAL. This interview benefit is in the 11% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.1% of applications are subsequently allowed. This success rate is in the 27% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 73.0% of cases where such amendments are filed. This entry rate is in the 93% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 82% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 90.5% of appeals filed. This is in the 83% percentile among all examiners. Of these withdrawals, 63.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 82.8% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.5% of allowed cases (in the 60% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.